APO Research
Talk to an analyst

APO RESEARCH · REPORT

Livestock Animal Vaccines

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.

Selected research

Market Outlook & Growth Opportunities

Global Livestock Animal Vaccines Market Outlook and Growth Opportunities 2026

28 December 2025202 pages

Choose your research edition.

Industry ResearchLivestock Animal Vaccines Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Livestock Animal Vaccines Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Livestock Animal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Livestock Animal Vaccines Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Livestock Animal Vaccines Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.

There are three kinds of Livestock Animal Vaccine, which are Live Attenuated Vaccines, Inactivated Vaccines and others. Live attenuated vaccines hold the largest share of the Livestock Animal Vaccines market, with a sales market share nearly 53.75% in 2019. Livestock Animal Vaccine is use in Pig, Cattle, Poultry and Other. The most proportion of Livestock Animal Vaccine is used in Cattle, and the market share in 2019 is about 34.73% and the proportion of Pigs in 2019 is about 23.35%. Market competition is intense; Merck, Zoetis, Boehringer Ingelheim, Ceva, etc. are the leader of the industry, and top 5 players hold about 70.27% revenue market share, with high-end customers.

This report provides an overview of the global Livestock Animal Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Livestock Animal Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Livestock Animal Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Livestock Animal Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Livestock Animal Vaccines Segment by Company

Merck

Boehringer Ingelheim

Zoetis

Ceva

Elanco

CAHIC

Jinyu Bio-Technology

HVRI

Ringpu Biology

Yebio

DHN

Kyoto Biken Laboratories

WINSUN

FATRO

CAVAC

MEVAC

Biovac

ChengDu Tecbond

Vaksindo

Bio-Labs

Livestock Animal Vaccines Segment by Type

Live Attenuated Vaccine

Inactivated Vaccine

Other Vaccines

Livestock Animal Vaccines Segment by Application

Pig

Cattle

Poultry

Others

Livestock Animal Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Livestock Animal Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Livestock Animal Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Livestock Animal Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Livestock Animal Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Livestock Animal Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Livestock Animal Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Livestock Animal Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Livestock Animal Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Livestock Animal Vaccines industry.

Chapter 3: Detailed analysis of Livestock Animal Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Livestock Animal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Livestock Animal Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Livestock Animal Vaccines Industry Trends Table 2. Livestock Animal Vaccines Industry Drivers Table 3. Livestock Animal Vaccines Industry Opportunities and Challenges Table 4. Livestock Animal Vaccines Industry Restraints Table 5. Global Livestock Animal Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Livestock Animal Vaccines Revenue Share by Company (2021-2026) Table 7. Global Livestock Animal Vaccines Sales Volume by Company (M Doses) & (2021-2026) Table 8. Global Livestock Animal Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Livestock Animal Vaccines Average Price (USD/K Doses) of Company (2021-2026) Table 10. Global Livestock Animal Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Livestock Animal Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Livestock Animal Vaccines Company, Product Type & Application Table 13. Global Livestock Animal Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Livestock Animal Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Live Attenuated Vaccine Table 18. Significant Companies of Inactivated Vaccine Table 19. Significant Companies of Other Vaccines Table 20. Global Livestock Animal Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (M Doses) Table 21. Global Livestock Animal Vaccines Sales Volume by Type (2021-2026) & (M Doses) Table 22. Global Livestock Animal Vaccines Sales Volume by Type (2027-2032) & (M Doses) Table 23. Global Livestock Animal Vaccines Sales Volume Share by Type (2021-2026) Table 24. Global Livestock Animal Vaccines Sales Volume Share by Type (2027-2032) Table 25. Global Livestock Animal Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Livestock Animal Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Livestock Animal Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Livestock Animal Vaccines Sales Value Share by Type (2021-2026) Table 29. Global Livestock Animal Vaccines Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Pig Table 31. Significant Companies of Cattle Table 32. Significant Companies of Poultry Table 33. Significant Companies of Others Table 34. Global Livestock Animal Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (M Doses) Table 35. Global Livestock Animal Vaccines Sales Volume by Application (2021-2026) & (M Doses) Table 36. Global Livestock Animal Vaccines Sales Volume by Application (2027-2032) & (M Doses) Table 37. Global Livestock Animal Vaccines Sales Volume Share by Application (2021-2026) Table 38. Global Livestock Animal Vaccines Sales Volume Share by Application (2027-2032) Table 39. Global Livestock Animal Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Livestock Animal Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Livestock Animal Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Livestock Animal Vaccines Sales Value Share by Application (2021-2026) Table 43. Global Livestock Animal Vaccines Sales Value Share by Application (2027-2032) Table 44. Global Livestock Animal Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 45. Global Livestock Animal Vaccines Sales by Region (2021-2026) & (M Doses) Table 46. Global Livestock Animal Vaccines Sales Market Share by Region (2021-2026) Table 47. Global Livestock Animal Vaccines Sales by Region (2027-2032) & (M Doses) Table 48. Global Livestock Animal Vaccines Sales Market Share by Region (2027-2032) Table 49. Global Livestock Animal Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Livestock Animal Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Livestock Animal Vaccines Sales Value Share by Region (2021-2026) Table 52. Global Livestock Animal Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Livestock Animal Vaccines Sales Value Share by Region (2027-2032) Table 54. Global Livestock Animal Vaccines Market Average Price (USD/K Doses) by Region (2021-2026) Table 55. Global Livestock Animal Vaccines Market Average Price (USD/K Doses) by Region (2027-2032) Table 56. Global Livestock Animal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Table 57. Global Livestock Animal Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Livestock Animal Vaccines Sales by Country (2021-2026) & (M Doses) Table 59. Global Livestock Animal Vaccines Sales Market Share by Country (2021-2026) Table 60. Global Livestock Animal Vaccines Sales by Country (2027-2032) & (M Doses) Table 61. Global Livestock Animal Vaccines Sales Market Share by Country (2027-2032) Table 62. Global Livestock Animal Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Livestock Animal Vaccines Sales Value Market Share by Country (2021-2026) Table 64. Global Livestock Animal Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Livestock Animal Vaccines Sales Value Market Share by Country (2027-2032) Table 66. Merck Company Information Table 67. Merck Business Overview Table 68. Merck Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 69. Merck Livestock Animal Vaccines Product Portfolio Table 70. Merck Recent Development Table 71. Boehringer Ingelheim Company Information Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 74. Boehringer Ingelheim Livestock Animal Vaccines Product Portfolio Table 75. Boehringer Ingelheim Recent Development Table 76. Zoetis Company Information Table 77. Zoetis Business Overview Table 78. Zoetis Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 79. Zoetis Livestock Animal Vaccines Product Portfolio Table 80. Zoetis Recent Development Table 81. Ceva Company Information Table 82. Ceva Business Overview Table 83. Ceva Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 84. Ceva Livestock Animal Vaccines Product Portfolio Table 85. Ceva Recent Development Table 86. Elanco Company Information Table 87. Elanco Business Overview Table 88. Elanco Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 89. Elanco Livestock Animal Vaccines Product Portfolio Table 90. Elanco Recent Development Table 91. CAHIC Company Information Table 92. CAHIC Business Overview Table 93. CAHIC Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 94. CAHIC Livestock Animal Vaccines Product Portfolio Table 95. CAHIC Recent Development Table 96. Jinyu Bio-Technology Company Information Table 97. Jinyu Bio-Technology Business Overview Table 98. Jinyu Bio-Technology Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 99. Jinyu Bio-Technology Livestock Animal Vaccines Product Portfolio Table 100. Jinyu Bio-Technology Recent Development Table 101. HVRI Company Information Table 102. HVRI Business Overview Table 103. HVRI Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 104. HVRI Livestock Animal Vaccines Product Portfolio Table 105. HVRI Recent Development Table 106. Ringpu Biology Company Information Table 107. Ringpu Biology Business Overview Table 108. Ringpu Biology Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 109. Ringpu Biology Livestock Animal Vaccines Product Portfolio Table 110. Ringpu Biology Recent Development Table 111. Yebio Company Information Table 112. Yebio Business Overview Table 113. Yebio Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 114. Yebio Livestock Animal Vaccines Product Portfolio Table 115. Yebio Recent Development Table 116. DHN Company Information Table 117. DHN Business Overview Table 118. DHN Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 119. DHN Livestock Animal Vaccines Product Portfolio Table 120. DHN Recent Development Table 121. Kyoto Biken Laboratories Company Information Table 122. Kyoto Biken Laboratories Business Overview Table 123. Kyoto Biken Laboratories Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 124. Kyoto Biken Laboratories Livestock Animal Vaccines Product Portfolio Table 125. Kyoto Biken Laboratories Recent Development Table 126. WINSUN Company Information Table 127. WINSUN Business Overview Table 128. WINSUN Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 129. WINSUN Livestock Animal Vaccines Product Portfolio Table 130. WINSUN Recent Development Table 131. FATRO Company Information Table 132. FATRO Business Overview Table 133. FATRO Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 134. FATRO Livestock Animal Vaccines Product Portfolio Table 135. FATRO Recent Development Table 136. CAVAC Company Information Table 137. CAVAC Business Overview Table 138. CAVAC Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 139. CAVAC Livestock Animal Vaccines Product Portfolio Table 140. CAVAC Recent Development Table 141. MEVAC Company Information Table 142. MEVAC Business Overview Table 143. MEVAC Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 144. MEVAC Livestock Animal Vaccines Product Portfolio Table 145. MEVAC Recent Development Table 146. Biovac Company Information Table 147. Biovac Business Overview Table 148. Biovac Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 149. Biovac Livestock Animal Vaccines Product Portfolio Table 150. Biovac Recent Development Table 151. ChengDu Tecbond Company Information Table 152. ChengDu Tecbond Business Overview Table 153. ChengDu Tecbond Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 154. ChengDu Tecbond Livestock Animal Vaccines Product Portfolio Table 155. ChengDu Tecbond Recent Development Table 156. Vaksindo Company Information Table 157. Vaksindo Business Overview Table 158. Vaksindo Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 159. Vaksindo Livestock Animal Vaccines Product Portfolio Table 160. Vaksindo Recent Development Table 161. Bio-Labs Company Information Table 162. Bio-Labs Business Overview Table 163. Bio-Labs Livestock Animal Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 164. Bio-Labs Livestock Animal Vaccines Product Portfolio Table 165. Bio-Labs Recent Development Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Livestock Animal Vaccines Distributors List Table 169. Livestock Animal Vaccines Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Livestock Animal Vaccines Product Image Figure 2. Global Livestock Animal Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Livestock Animal Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Livestock Animal Vaccines Sales (2021-2032) & (M Doses) Figure 5. Global Livestock Animal Vaccines Sales Average Price (USD/K Doses) & (2021-2032) Figure 6. Global Livestock Animal Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Live Attenuated Vaccine Image Figure 10. Inactivated Vaccine Image Figure 11. Other Vaccines Image Figure 12. Global Livestock Animal Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 13. Global Livestock Animal Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Livestock Animal Vaccines Sales Volume Share by Type (2021-2032) Figure 15. Global Livestock Animal Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Livestock Animal Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Livestock Animal Vaccines Sales Value Share by Type (2021-2032) Figure 18. Pig Image Figure 19. Cattle Image Figure 20. Poultry Image Figure 21. Others Image Figure 22. Global Livestock Animal Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 23. Global Livestock Animal Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Livestock Animal Vaccines Sales Volume Share by Application (2021-2032) Figure 25. Global Livestock Animal Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Livestock Animal Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Livestock Animal Vaccines Sales Value Share by Application (2021-2032) Figure 28. Global Livestock Animal Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 29. Global Livestock Animal Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Livestock Animal Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Livestock Animal Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Livestock Animal Vaccines Sales Value (2021-2032) & (US$ Million) Figure 33. North America Livestock Animal Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Livestock Animal Vaccines Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Livestock Animal Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Livestock Animal Vaccines Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Livestock Animal Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Livestock Animal Vaccines Sales Value (2021-2032) & (US$ Million) Figure 39. South America Livestock Animal Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Livestock Animal Vaccines Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Livestock Animal Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Livestock Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Livestock Animal Vaccines Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Livestock Animal Vaccines Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Other Vaccines
Applications
  • Pig
  • Cattle
  • Poultry
  • Others
Companies covered
  • Merck
  • Boehringer Ingelheim
  • Zoetis
  • Ceva
  • Elanco
  • CAHIC
  • Jinyu Bio-Technology
  • HVRI
  • Ringpu Biology
  • Yebio
  • DHN
  • Kyoto Biken Laboratories
  • WINSUN
  • FATRO
  • CAVAC
  • MEVAC
  • Biovac
  • ChengDu Tecbond
  • Vaksindo
  • Bio-Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Livestock Animal Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Livestock Animal Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Livestock Animal Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Livestock Animal Vaccines Market Dynamics
  1. 2.1 Livestock Animal Vaccines Industry Trends
  2. 2.2 Livestock Animal Vaccines Industry Drivers
  3. 2.3 Livestock Animal Vaccines Industry Opportunities and Challenges
  4. 2.4 Livestock Animal Vaccines Industry Restraints
3 Livestock Animal Vaccines Market by Company
  1. 3.1 Global Livestock Animal Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Livestock Animal Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Livestock Animal Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Livestock Animal Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Livestock Animal Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Livestock Animal Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Livestock Animal Vaccines Company Product Type and Application
  8. 3.8 Global Livestock Animal Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Livestock Animal Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Livestock Animal Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Livestock Animal Vaccines Market by Type
  1. 4.1 Livestock Animal Vaccines Type Introduction
  2. 4.1.1 Live Attenuated Vaccine
  3. 4.1.2 Inactivated Vaccine
  4. 4.1.3 Other Vaccines
  5. 4.2 Global Livestock Animal Vaccines Sales Volume by Type
  6. 4.2.1 Global Livestock Animal Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Livestock Animal Vaccines Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Livestock Animal Vaccines Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Livestock Animal Vaccines Sales Value by Type
  10. 4.3.1 Global Livestock Animal Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Livestock Animal Vaccines Sales Value by Type (2021-2032)
  12. 4.3.3 Global Livestock Animal Vaccines Sales Value Share by Type (2021-2032)
5 Livestock Animal Vaccines Market by Application
  1. 5.1 Livestock Animal Vaccines Application Introduction
  2. 5.1.1 Pig
  3. 5.1.2 Cattle
  4. 5.1.3 Poultry
  5. 5.1.4 Others
  6. 5.2 Global Livestock Animal Vaccines Sales Volume by Application
  7. 5.2.1 Global Livestock Animal Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Livestock Animal Vaccines Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Livestock Animal Vaccines Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Livestock Animal Vaccines Sales Value by Application
  11. 5.3.1 Global Livestock Animal Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Livestock Animal Vaccines Sales Value by Application (2021-2032)
  13. 5.3.3 Global Livestock Animal Vaccines Sales Value Share by Application (2021-2032)
6 Livestock Animal Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Livestock Animal Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Livestock Animal Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Livestock Animal Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Livestock Animal Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Livestock Animal Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Livestock Animal Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Livestock Animal Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Livestock Animal Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Livestock Animal Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Livestock Animal Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Livestock Animal Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Livestock Animal Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Livestock Animal Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Livestock Animal Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Livestock Animal Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Livestock Animal Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Livestock Animal Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Livestock Animal Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Livestock Animal Vaccines Sales Value Share by Country, 2025 VS 2032
7 Livestock Animal Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Livestock Animal Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Livestock Animal Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Livestock Animal Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Livestock Animal Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Livestock Animal Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Livestock Animal Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Livestock Animal Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Livestock Animal Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Livestock Animal Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Livestock Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Livestock Animal Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Livestock Animal Vaccines Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Livestock Animal Vaccines Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Zoetis
  14. 8.3.1 Zoetis Company Information
  15. 8.3.2 Zoetis Business Overview
  16. 8.3.3 Zoetis Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Zoetis Livestock Animal Vaccines Product Portfolio
  18. 8.3.5 Zoetis Recent Developments
  19. 8.4 Ceva
  20. 8.4.1 Ceva Company Information
  21. 8.4.2 Ceva Business Overview
  22. 8.4.3 Ceva Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ceva Livestock Animal Vaccines Product Portfolio
  24. 8.4.5 Ceva Recent Developments
  25. 8.5 Elanco
  26. 8.5.1 Elanco Company Information
  27. 8.5.2 Elanco Business Overview
  28. 8.5.3 Elanco Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Elanco Livestock Animal Vaccines Product Portfolio
  30. 8.5.5 Elanco Recent Developments
  31. 8.6 CAHIC
  32. 8.6.1 CAHIC Company Information
  33. 8.6.2 CAHIC Business Overview
  34. 8.6.3 CAHIC Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 CAHIC Livestock Animal Vaccines Product Portfolio
  36. 8.6.5 CAHIC Recent Developments
  37. 8.7 Jinyu Bio-Technology
  38. 8.7.1 Jinyu Bio-Technology Company Information
  39. 8.7.2 Jinyu Bio-Technology Business Overview
  40. 8.7.3 Jinyu Bio-Technology Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jinyu Bio-Technology Livestock Animal Vaccines Product Portfolio
  42. 8.7.5 Jinyu Bio-Technology Recent Developments
  43. 8.8 HVRI
  44. 8.8.1 HVRI Company Information
  45. 8.8.2 HVRI Business Overview
  46. 8.8.3 HVRI Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 HVRI Livestock Animal Vaccines Product Portfolio
  48. 8.8.5 HVRI Recent Developments
  49. 8.9 Ringpu Biology
  50. 8.9.1 Ringpu Biology Company Information
  51. 8.9.2 Ringpu Biology Business Overview
  52. 8.9.3 Ringpu Biology Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Ringpu Biology Livestock Animal Vaccines Product Portfolio
  54. 8.9.5 Ringpu Biology Recent Developments
  55. 8.10 Yebio
  56. 8.10.1 Yebio Company Information
  57. 8.10.2 Yebio Business Overview
  58. 8.10.3 Yebio Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Yebio Livestock Animal Vaccines Product Portfolio
  60. 8.10.5 Yebio Recent Developments
  61. 8.11 DHN
  62. 8.11.1 DHN Company Information
  63. 8.11.2 DHN Business Overview
  64. 8.11.3 DHN Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 DHN Livestock Animal Vaccines Product Portfolio
  66. 8.11.5 DHN Recent Developments
  67. 8.12 Kyoto Biken Laboratories
  68. 8.12.1 Kyoto Biken Laboratories Company Information
  69. 8.12.2 Kyoto Biken Laboratories Business Overview
  70. 8.12.3 Kyoto Biken Laboratories Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Kyoto Biken Laboratories Livestock Animal Vaccines Product Portfolio
  72. 8.12.5 Kyoto Biken Laboratories Recent Developments
  73. 8.13 WINSUN
  74. 8.13.1 WINSUN Company Information
  75. 8.13.2 WINSUN Business Overview
  76. 8.13.3 WINSUN Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 WINSUN Livestock Animal Vaccines Product Portfolio
  78. 8.13.5 WINSUN Recent Developments
  79. 8.14 FATRO
  80. 8.14.1 FATRO Company Information
  81. 8.14.2 FATRO Business Overview
  82. 8.14.3 FATRO Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 FATRO Livestock Animal Vaccines Product Portfolio
  84. 8.14.5 FATRO Recent Developments
  85. 8.15 CAVAC
  86. 8.15.1 CAVAC Company Information
  87. 8.15.2 CAVAC Business Overview
  88. 8.15.3 CAVAC Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 CAVAC Livestock Animal Vaccines Product Portfolio
  90. 8.15.5 CAVAC Recent Developments
  91. 8.16 MEVAC
  92. 8.16.1 MEVAC Company Information
  93. 8.16.2 MEVAC Business Overview
  94. 8.16.3 MEVAC Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 MEVAC Livestock Animal Vaccines Product Portfolio
  96. 8.16.5 MEVAC Recent Developments
  97. 8.17 Biovac
  98. 8.17.1 Biovac Company Information
  99. 8.17.2 Biovac Business Overview
  100. 8.17.3 Biovac Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Biovac Livestock Animal Vaccines Product Portfolio
  102. 8.17.5 Biovac Recent Developments
  103. 8.18 ChengDu Tecbond
  104. 8.18.1 ChengDu Tecbond Company Information
  105. 8.18.2 ChengDu Tecbond Business Overview
  106. 8.18.3 ChengDu Tecbond Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 ChengDu Tecbond Livestock Animal Vaccines Product Portfolio
  108. 8.18.5 ChengDu Tecbond Recent Developments
  109. 8.19 Vaksindo
  110. 8.19.1 Vaksindo Company Information
  111. 8.19.2 Vaksindo Business Overview
  112. 8.19.3 Vaksindo Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Vaksindo Livestock Animal Vaccines Product Portfolio
  114. 8.19.5 Vaksindo Recent Developments
  115. 8.20 Bio-Labs
  116. 8.20.1 Bio-Labs Company Information
  117. 8.20.2 Bio-Labs Business Overview
  118. 8.20.3 Bio-Labs Livestock Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Bio-Labs Livestock Animal Vaccines Product Portfolio
  120. 8.20.5 Bio-Labs Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Livestock Animal Vaccines Value Chain Analysis
  2. 9.1.1 Livestock Animal Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Livestock Animal Vaccines Sales Mode & Process
  6. 9.2 Livestock Animal Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Livestock Animal Vaccines Distributors
  9. 9.2.3 Livestock Animal Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst